LON:UDG - Udg Healthcare Stock Price, News & Analysis

GBX 756
+4.50 (+0.60 %)
(As of 09/19/2019 07:34 AM ET)
Today's Range
742.50
Now: GBX 756
760.50
50-Day Range
739
MA: GBX 785.04
821
52-Week Range
545
Now: GBX 756
833
Volume120,933 shs
Average Volume981,360 shs
Market Capitalization£1.88 billion
P/E Ratio73.40
Dividend Yield1.65%
BetaN/A
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. Read More…

Industry, Sector and Symbol

Industry Medical Distribution
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+353-1-4689000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£1.30 billion
Cash FlowGBX 69.05 per share
Book ValueGBX 358.70 per share

Profitability

Miscellaneous

Employees8,700
Market Cap£1.88 billion
Next Earnings Date11/26/2019 (Estimated)
OptionableNot Optionable

Receive UDG News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG and its competitors with MarketBeat's FREE daily newsletter.


Udg Healthcare (LON:UDG) Frequently Asked Questions

What is Udg Healthcare's stock symbol?

Udg Healthcare trades on the London Stock Exchange (LON) under the ticker symbol "UDG."

How often does Udg Healthcare pay dividends? What is the dividend yield for Udg Healthcare?

Udg Healthcare declared a dividend on Tuesday, May 21st. Stockholders of record on Thursday, May 30th will be paid a dividend of GBX 0.04 per share on Wednesday, June 26th. This represents a dividend yield of 0.5%. The ex-dividend date is Thursday, May 30th. The official announcement can be accessed at this link. View Udg Healthcare's Dividend History.

When is Udg Healthcare's next earnings date?

Udg Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, November 26th 2019. View Earnings Estimates for Udg Healthcare.

What price target have analysts set for UDG?

7 brokerages have issued 12 month price targets for Udg Healthcare's stock. Their predictions range from GBX 620 to GBX 1,165. On average, they expect Udg Healthcare's stock price to reach GBX 814.14 in the next year. This suggests a possible upside of 7.7% from the stock's current price. View Analyst Price Targets for Udg Healthcare.

What is the consensus analysts' recommendation for Udg Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Udg Healthcare in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Udg Healthcare.

Has Udg Healthcare been receiving favorable news coverage?

Media stories about UDG stock have been trending negative this week, InfoTrie reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Udg Healthcare earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Udg Healthcare.

Who are some of Udg Healthcare's key competitors?

What other stocks do shareholders of Udg Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Udg Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), Standard Life Aberdeen (SL), CRH (CRH), Carclo (CAR), Greencore Group (GNC), CBS (CBS), freenet (FNTN), Aviva (AV) and BT Group - CLASS A (BT.A).

Who are Udg Healthcare's key executives?

Udg Healthcare's management team includes the folowing people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 56)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 45)
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications
  • Eleanor Garvey, Group Head of Quality & Compliance
  • Mr. Damien Moynagh, Gen. Counsel & Company Sec.

How do I buy shares of Udg Healthcare?

Shares of UDG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Udg Healthcare's stock price today?

One share of UDG stock can currently be purchased for approximately GBX 756.

How big of a company is Udg Healthcare?

Udg Healthcare has a market capitalization of £1.88 billion and generates £1.30 billion in revenue each year. Udg Healthcare employs 8,700 workers across the globe.View Additional Information About Udg Healthcare.

What is Udg Healthcare's official website?

The official website for Udg Healthcare is http://www.udghealthcare.com/.

How can I contact Udg Healthcare?

Udg Healthcare's mailing address is River Walk 20, DUBLIN,, Ireland. The company can be reached via phone at +353-1-4689000.


MarketBeat Community Rating for Udg Healthcare (LON UDG)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  471 (Vote Outperform)
Underperform Votes:  322 (Vote Underperform)
Total Votes:  793
MarketBeat's community ratings are surveys of what our community members think about Udg Healthcare and other stocks. Vote "Outperform" if you believe UDG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UDG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel